Farooq A, Zulfiqar B, Asghar K. Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma. J Cancer Allied Spec [Internet]. 2022Sep.30 [cited 2024Apr.24];9(1). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/501